Boy or Girl?

Blood tests can accurately determine a fetus’s gender as early as 7 weeks.

By | August 11, 2011

STOCK.XCHNG, MILAN6

Tests that analyze fetal DNA in the mother’s blood can be used to reliably determine the fetus’s gender as early as 7 weeks after gestation—many weeks earlier than other tests. According to a new study published in the Journal of the American Medical Association, if performed correctly, these cell-free fetal DNA tests can determine sex with 95 percent accuracy.

But while such tests could be very useful for parents whose offspring are at risk for rare gender-linked disorders such as Duchenne muscular dystrophy, they run the risk of being used for more controversial purposes, such as gender selecting the New York Times reports. Currently, the tests are not regulated by the US Food and Drug Administration, deterring many doctors from prescribing them in the United States, although in Europe they’re routinely used on people with high risk of gender-linked diseases.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Melvin Donaldson

Melvin Donaldson

Posts: 1457

August 11, 2011

You should be more careful, these tests do not determine gender but sex.

Avatar of:

Posts: 0

August 11, 2011

You should be more careful, these tests do not determine gender but sex.

Avatar of:

Posts: 0

August 11, 2011

You should be more careful, these tests do not determine gender but sex.

Avatar of:

Posts: 0

August 12, 2011

The technology can not be introduced into China, where one-child policy is carried out.

Avatar of: Twangcn

Anonymous

August 12, 2011

The technology can not be introduced into China, where one-child policy is carried out.

Avatar of:

Posts: 0

August 12, 2011

The technology can not be introduced into China, where one-child policy is carried out.

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham